XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Balance (in shares) at Apr. 03, 2021     50,869 0            
Balance at Apr. 03, 2021 $ 731,670 $ (60,121) $ 509 $ 0 $ 602,727 $ (61,156) $ 157,981 $ 1,035 $ (29,547) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Employee stock purchase plan (in shares)     39              
Employee stock purchase plan 2,210       2,210          
Exercise of stock options (in shares)     14              
Exercise of stock options 500   $ 0   500          
Issuance of restricted stock, net of cancellations (in shares)     91              
Issuance of restricted stock, net of cancellations 0   $ 1   (1)   0      
Share-based compensation expense 6,828       6,828          
Net income (4,454)           (4,454)      
Other comprehensive income (loss) 447           0   447  
Balance (in shares) at Jul. 03, 2021     51,013              
Balance at Jul. 03, 2021 677,080   $ 510   551,108   154,562   (29,100)  
Balance (in shares) at Apr. 03, 2021     50,869 0            
Balance at Apr. 03, 2021 731,670 $ (60,121) $ 509 $ 0 602,727 $ (61,156) 157,981 $ 1,035 (29,547) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 10,402                  
Balance (in shares) at Oct. 02, 2021     51,060              
Balance at Oct. 02, 2021 698,549   $ 511   558,156   169,418   (29,536)  
Balance (in shares) at Jul. 03, 2021     51,013              
Balance at Jul. 03, 2021 677,080   $ 510   551,108   154,562   (29,100)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)     28              
Exercise of stock options 1,070   $ 1   1,069          
Issuance of restricted stock, net of cancellations (in shares)     19              
Share-based compensation expense 5,979       5,979          
Net income 14,856           14,856      
Other comprehensive income (loss) (436)               (436)  
Balance (in shares) at Oct. 02, 2021     51,060              
Balance at Oct. 02, 2021 698,549   $ 511   558,156   169,418   (29,536)  
Balance (in shares) at Apr. 02, 2022     51,124              
Balance at Apr. 02, 2022 749,424   $ 511   572,476   202,391   (25,954)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Employee stock purchase plan (in shares)     57              
Employee stock purchase plan 2,459       2,459          
Exercise of stock options (in shares)     3              
Exercise of stock options 127   $ 1   126          
Issuance of restricted stock, net of cancellations (in shares)     131              
Issuance of restricted stock, net of cancellations 0   $ 1   (1)          
Share-based compensation expense 5,299       5,299          
Net income 19,877           19,877      
Other comprehensive income (loss) (6,763)               (6,763)  
Balance (in shares) at Jul. 02, 2022     51,315              
Balance at Jul. 02, 2022 770,423   $ 513   580,359   222,268   (32,717)  
Balance (in shares) at Apr. 02, 2022     51,124              
Balance at Apr. 02, 2022 749,424   $ 511   572,476   202,391   (25,954)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 53,074                  
Other comprehensive income (loss) (14,301)                  
Balance (in shares) at Oct. 01, 2022     50,605              
Balance at Oct. 01, 2022 729,009   $ 506   564,394   204,364   (40,255)  
Balance (in shares) at Jul. 02, 2022     51,315              
Balance at Jul. 02, 2022 770,423   $ 513   580,359   222,268   (32,717)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options (in shares)     50              
Exercise of stock options $ 2,192   $ 1   2,191          
Shares repurchased (in shares) (786)                  
Shares repurchased $ (75,000)   $ (8)   (23,891)   (51,101)      
Issuance of restricted stock, net of cancellations (in shares)     26              
Share-based compensation expense 5,735       5,735          
Net income 33,197           33,197      
Other comprehensive income (loss) (7,538)               (7,538)  
Balance (in shares) at Oct. 01, 2022     50,605              
Balance at Oct. 01, 2022 $ 729,009   $ 506   $ 564,394   $ 204,364   $ (40,255)